BEGIN:VCALENDAR
VERSION:2.0
CALSCALE:GREGORIAN
BEGIN:VEVENT
URL:https://www.learndesk.us/class/6031358776311808/lesson/beb26ac37c7836cffcce656fbdcd7885?ref=outlook-calendar
SUMMARY:UNIT 16 
DTSTART;TZID=America/Los_Angeles:20260501T190000
DTEND;TZID=America/Los_Angeles:20260501T200000
LOCATION:https://www.learndesk.us/class/6031358776311808/lesson/beb26ac37c7836cffcce656fbdcd7885?ref=outlook-calendar
DESCRIPTION: When used for the secondary prevention of cardiovascular disease, the benefits of a prolonged course of aspirin (acetylsalicylic acid) therapy at low doses (75–100 mg daily) clearly outweigh the risks of bleeding, but whether to recommend aspirin for the primary prevention of cardiovascular disease has long been debated. Primary prevention includes those preventive measures that come before the onset of illness or injury and before the disease process begins. Secondary prevention includes those preventive measures that lead to early diagnosis and prompt treatment of a disease, illness, or injury. Tertiary prevention aims to soften the impact of an ongoing illness or injury that has lasting effects. The evidence from randomised clinical trials of aspirin therapy versus placebo (or control therapy) has accumulated steadily since the first trials were reported 30 years ago. However, no clear consensus exists about whether, and if so in whom, aspirin therapy is appropriate for...

https://www.learndesk.us/class/6031358776311808/lesson/beb26ac37c7836cffcce656fbdcd7885?ref=outlook-calendar
STATUS:CONFIRMED
SEQUENCE:3
BEGIN:VALARM
TRIGGER:-PT10M
DESCRIPTION:Class Reminder
ACTION:DISPLAY
END:VALARM
END:VEVENT
END:VCALENDAR